CQC will check new guidance in Cass report is applied by private care providers to avoid ‘two-tier’ access to drugs
England’s health regulator will take enforcement action against private clinics that prescribe puberty blockers to under-18s in defiance of the NHS’s ban on the controversial drugs.
The Care Quality Commission (CQC) will check that private providers of care to those who are questioning their gender identity are applying new guidance recommended by Dr Hilary Cass.
Continue reading…
